Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research explores how SS-31 peptide nanoparticles may restore mitochondrial function and reduce inflammation in ulcerative colitis. Learn what the study found.
By Peptide Association Research Team
New research suggests the SS-31 peptide may help treat ulcerative colitis by restoring mitochondrial function and reprogramming immune cells. Learn what the study found.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction and lasting cognitive impairment in aged rats. What does it mean for patients?
By Peptide Association Research Team
New research in aged rats suggests opioid use after surgery disrupts hippocampal mitochondria, contributing to long-term cognitive decline. Learn what the findings mean.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction in aged rats, suggesting a potential target for treating postoperative cognitive decline.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives postoperative cognitive decline and which peptide-based therapies show promise in preclinical studies.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction and cognitive decline in aged rats. Learn what the findings mean for patients.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy by reducing oxidative stress.
By Peptide Association Research Team
New research explores how mitochondria-targeted peptide nanoparticles may protect the liver from ischemia-reperfusion injury. Learn what the science shows.
By Peptide Association Research Team
A 2026 ACS Nano study suggests mitochondria-targeted nanoparticles may reduce liver ischemia-reperfusion injury by limiting ROS and inflammation in mice.
By Peptide Association Research Team
New research explores how mitochondria-targeted polydopamine nanoparticles modified with SS-31 peptide may protect the liver from ischemia-reperfusion injury.
By Peptide Association Research Team
Recent research explores mitochondrial-targeted liposomes containing SS-31 peptide for obesity treatment. Study shows improved fat metabolism in animal models.
By Peptide Association Research Team
Breakthrough study reveals how SS-31 peptide and targeted liposomes may enhance fat burning by improving mitochondrial function in adipose tissue.
By Peptide Association Research Team
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team